セルベースアッセイ市場レポート：製品・サービス、技術、用途、エンドユーザー、地域別、2024-2032

世界のセルベースアッセイ市場規模は2023年に225億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて7.2%の成長率（CAGR）を示し、2032年までに429億米ドルに達すると予測しています。さまざまな疾患に対処するための新規治療に対する需要の高まり、個別化医療への注目の高まり、薬剤スクリーニングの精度を向上させるための細胞培養技術の革新などが、市場を推進する主な要因の一部です。

セルベースアッセイは、特定の物質や条件に反応する細胞の生物学的活性を評価するために、様々な科学・医療分野で使用される実験技術です。制御された環境で生きた細胞を培養し、薬物、化合物、環境因子などの様々な刺激にさらすことからなります。細胞の生存率や特定のバイオマーカーの発現など、細胞の挙動における変化をモニターすることで、研究者は試験物質が細胞機能に及ぼす影響について重要な洞察を得ることができるため、細胞ベースのアッセイに対する需要は世界的に高まっています。

現在、創薬、毒性学研究、疾患モデリング、細胞メカニズムの解明などのためにセルベースアッセイの採用が増加しており、市場の成長を支えています。これに加えて、医薬化合物の潜在的な有効性と安全性を評価するニーズの高まりが、市場の成長を強化しています。さらに、研究者が市場開拓の初期段階で潜在的な副作用を特定し、化学物質の毒性を評価することを可能にする細胞ベースのアッセイに対する需要の高まりは、市場にプラスの影響を与えています。これとは別に、がん、糖尿病、自己免疫疾患などの慢性疾患が世界中で増加していることも、業界の投資家に有利な成長機会をもたらしています。さらに、化学物質や汚染物質が植物や水生システムに与える影響を評価する必要性の高まりが、市場の成長を後押ししています。

セルベースアッセイ市場の動向と促進要因：

様々な疾患に対処するための新規治療に対する需要の高まり

創薬・薬剤開発への注目の高まりに加え、世界中の人々の間で様々な慢性疾患に対処するための新規療法への需要が高まっていることが、市場の成長に寄与しています。加えて、細胞ベースのアッセイは、研究者が膨大な数の潜在的な薬剤候補を迅速かつ効率的にスクリーニングし、評価することを可能にします。細胞をさまざまな化合物に暴露することで、科学者はその有効性や安全性プロファイルなど、細胞の挙動への影響を評価することができます。これとは別に、薬剤が特定の細胞経路とどのように相互作用するかを深く理解する必要がある精密医療への注目が高まっています。さらに、これらのアッセイは、個々の患者のプロファイルに合わせて薬物治療を調整するためのプラットフォームを提供します。

個別化医療への注目の高まり

大衆の間で個別化医薬品への注目が高まっていることが、市場の成長を支えています。これに伴い、ヘルスケア施設は、個々の患者の遺伝的、分子的、細胞的特徴に合わせてカスタマイズされた治療ソリューションに急速に注目しています。これに加えて、細胞ベースのアッセイによって、研究者は様々な薬剤や治療に対する患者由来の細胞の反応を評価することができ、潜在的な副作用を最小限に抑えながら、最も効果的な治療法を特定することが可能になります。さらに、個別化医療は治療成績を向上させるだけでなく、効果のない治療を避けることでヘルスケアコストを削減します。その結果、臨床と研究の両方の場面で細胞ベースのアッセイの採用が増加しています。細胞ベースのアッセイは、医療介入を患者の特定のニーズに合わせて調整するための強力なツールとなるからです。

細胞培養技術の革新

細胞培養技術の進歩は、細胞ベースのアッセイの能力を高めています。3D培養やオルガノイドにより、研究者はより人体に近い細胞挙動を研究し、薬剤スクリーニングや毒性試験の精度を向上させることができます。さらに、マイクロフルイディクスとラボオンチップ技術により、小型化・自動化されたセルベースアッセイの開発が可能になり、創薬のスループットと効率性の向上に寄与しています。これに伴い、これらの先進的な細胞培養技術を細胞ベースのアッセイに統合することで、その関連性と適用性を高めることができ、疾患メカニズムの解明や、より精度の高い医薬品候補の評価に適したツールとなります。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 セルベースアッセイの世界市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：製品・サービス別
• 市場内訳：技術別
• 市場内訳：用途別
• 市場内訳：エンドユーザー別
• 市場内訳：地域別
• 市場予測
• SWOT分析
  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威
• バリューチェーン分析
• ポーターのファイブフォース分析
  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第6章 市場内訳：製品・サービス別

• 消耗品
  • 試薬・メディア
    • 市場動向
    • 市場予測
  • 細胞・細胞株
    • 市場動向
    • 市場予測
  • プローブとラベル
    • 市場動向
    • 市場予測
• 機器
  • マイクロプレート
    • 市場動向
    • 市場予測
  • マイクロプレートリーダー
    • 市場動向
    • 市場予測
  • ハイスループットスクリーニング
    • 市場動向
    • 市場予測
  • リキッドハンドリングシステム
    • 市場動向
    • 市場予測
• サービス
  • 市場動向
  • 市場予測
• ソフトウェア
  • 市場動向
  • 市場予測

第7章 市場内訳：技術別

• 自動ハンドリング
  • 市場動向
  • 市場予測
• フローサイトメトリー
  • 市場動向
  • 市場予測
• ラベルフリー検出
  • 市場動向
  • 市場予測
• ハイスループットスクリーニング
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：用途別

• 創薬
  • 市場動向
  • 市場予測
• 基礎調査
  • 市場動向
  • 市場予測
• ADME研究
  • 市場動向
  • 市場予測
• 予測毒性学
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：エンドユーザー別

• 製薬・バイオ企業
  • 市場動向
  • 市場予測
• 学術・政府機関
  • 市場動向
  • 市場予測
• 受託研究機関
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：地域別

• 北米
  • 市場動向
  • 市場予測
• 欧州
  • 市場動向
  • 市場予測
• アジア太平洋
  • 市場動向
  • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場予測
• ラテンアメリカ
  • 市場動向
  • 市場予測

第11章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Becton, Dickinson and Company
  • Global Life Sciences Solutions USA LLC（DBA Cytiva）
  • Thermo Fisher Scientific Inc.
  • Merck Group
  • PerkinElmer Inc.
  • Charles River Laboratories Inc.
  • Lonza Group Ltd.
  • Cell Signaling Technology
  • Promega Corporation
  • Cell Biolabs Inc.
  • Eurofins DiscoverX Corporation
  • Bio-Rad Laboratories Inc.
  • Corning Inc.
  • F. Hoffmann-La Roche AG（Roche Holding AG）

List of Figures

• Figure 1: Global: Cell-Based Assay Market: Major Drivers and Challenges
• Figure 2: Global: Cell-Based Assay Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Cell-Based Assay Market: Breakup by Product and Services (in %), 2023
• Figure 4: Global: Cell-Based Assay Market: Breakup by Technology (in %), 2023
• Figure 5: Global: Cell-Based Assay Market: Breakup by Application (in %), 2023
• Figure 6: Global: Cell-Based Assay Market: Breakup by End-User (in %), 2023
• Figure 7: Global: Cell-Based Assay Market: Breakup by Region (in %), 2023
• Figure 8: Global: Cell-Based Assay Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 9: Global: Cell-Based Assay Industry: SWOT Analysis
• Figure 10: Global: Cell-Based Assay Industry: Value Chain Analysis
• Figure 11: Global: Cell-Based Assay Industry: Porter's Five Forces Analysis
• Figure 12: Global: Cell-Based Assay (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Cell-Based Assay (Consumables- Reagents and Media) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Cell-Based Assay (Consumables- Reagents and Media) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Cell-Based Assay (Consumables- Probes and Labels) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Cell-Based Assay (Consumables- Probes and Labels) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Cell-Based Assay (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Cell-Based Assay (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Cell-Based Assay (Instruments-Microplates) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Cell-Based Assay (Instruments-Microplates) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Cell-Based Assay (Instruments-Microplate Readers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Cell-Based Assay (Instruments- Microplate Readers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Cell-Based Assay (Instruments-High Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Cell-Based Assay (Instruments- High Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Cell-Based Assay (Instruments- Liquid Handling Systems) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Cell-Based Assay (Instruments-Liquid Handling Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Cell-Based Assay (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Global: Cell-Based Assay (Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Global: Cell-Based Assay (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Global: Cell-Based Assay (Software) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Global: Cell-Based Assay (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: Global: Cell-Based Assay (Automated Handling) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: Global: Cell-Based Assay (Automated Handling) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Global: Cell-Based Assay (Flow Cytometry) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Global: Cell-Based Assay (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: Global: Cell-Based Assay (Label-Free Detection) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: Global: Cell-Based Assay (Label-Free Detection) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Global: Cell-Based Assay (High-Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Global: Cell-Based Assay (High-Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Global: Cell-Based Assay (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Global: Cell-Based Assay (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Global: Cell-Based Assay (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Global: Cell-Based Assay (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Global: Cell-Based Assay (Basic Research) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Global: Cell-Based Assay (Basic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Global: Cell-Based Assay (ADME Studies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Global: Cell-Based Assay (ADME Studies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Global: Cell-Based Assay (Predictive Toxicology) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Global: Cell-Based Assay (Predictive Toxicology) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: Global: Cell-Based Assay (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: Global: Cell-Based Assay (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Global: Cell-Based Assay (Academic and Government Institutions) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Global: Cell-Based Assay (Academic and Government Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Global: Cell-Based Assay (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Global: Cell-Based Assay (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Global: Cell-Based Assay (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Global: Cell-Based Assay (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: North America: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: North America: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Europe: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Europe: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Asia Pacific: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Asia Pacific: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Middle East and Africa: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Middle East and Africa: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Latin America: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Latin America: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

• Table 1: Global: Cell-Based Assay Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Cell-Based Assay Market Forecast: Breakup by Product and Services (in Million US$), 2024-2032
• Table 3: Global: Cell-Based Assay Market Forecast: Breakup by Technology (in Million US$), 2024-2032
• Table 4: Global: Cell-Based Assay Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 5: Global: Cell-Based Assay Market Forecast: Breakup by End-User (in Million US$), 2024-2032
• Table 6: Global: Cell-Based Assay Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 7: Global: Cell-Based Assay Market: Competitive Structure
• Table 8: Global: Cell-Based Assay Market: Key Players

The global cell-based assay market size reached US$ 22.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032. The growing demand for novel therapies to address various diseases, rising focus on personalized medicines, and innovations in cell culture technologies to improve the accuracy of drug screening are some of the major factors propelling the market.

A cell-based assay, also known as a cellular assay, is a laboratory technique that is used in various scientific and medical fields to assess the biological activity of cells in response to specific substances or conditions. It comprises culturing living cells in controlled environments and exposing them to various stimuli, such as drugs, compounds, or environmental factors. As it allows researchers to gain critical insights into the effects of the tested substances on cellular function by monitoring changes in cell behavior, such as cell viability or the expression of specific biomarkers, the demand for cell-based assay is increasing worldwide.

At present, the rising adoption of cell-based assays for drug discovery, toxicology studies, disease modeling, and understanding cellular mechanisms is supporting the growth of the market. Besides this, the increasing need to evaluate the potential efficacy and safety of pharmaceutical compounds is strengthening the growth of the market. Additionally, the growing demand for cell-based assays, as they enable researchers to identify potential adverse effects early in the development process and assess the toxicity of chemicals, is positively influencing the market. Apart from this, increasing incidences of numerous chronic diseases, such as cancer, diabetes, and autoimmune disorders, among individuals around the world are offering lucrative growth opportunities to industry investors. Furthermore, the rising need to assess the impact of chemicals and pollutants on plant and aquatic systems is bolstering the growth of the market.

Cell-Based Assay Market Trends/Drivers:

Rising demand for novel therapies to address various diseases

The rising focus on drug discovery and development, along with the increasing demand for novel therapies to address various chronic diseases among individuals across the globe, is contributing to the growth of the market. In addition, cell-based assays enable researchers to screen and evaluate a vast number of potential drug candidates quickly and efficiently. By exposing cells to different compounds, scientists can assess their impact on cellular behavior, including their efficacy and safety profiles. Apart from this, there is an increase in the focus on precision medicine that necessitates a deep understanding of how drugs interact with specific cellular pathways. Moreover, these assays provide a platform for tailoring drug treatments to individual patient profiles.

Increasing focus on personalized medicines

The rising focus on personalized medicines among the masses is supporting the growth of the market. In line with this, healthcare facilities are rapidly focusing on treatment solutions that are customized to suit the genetic, molecular, and cellular characteristics of individual patients. Besides this, cell-based assays allow researchers to evaluate the response of patient-derived cells to various drugs and treatments and enable the identification of the most effective therapies while minimizing potential side effects. In addition, personalized medicine not only improves treatment outcomes but also reduces healthcare costs by avoiding ineffective treatments. As a result, there is an increase in the adoption of cell-based assays in both clinical and research settings, as they provide a powerful tool for tailoring medical interventions to the specific needs of patients.

Innovations in cell culture technologies

Advancements in cell culture techniques are enhancing the capabilities of cell-based assays. 3D cultures and organoids allow researchers to study cell behavior closer to the human body to improve the accuracy of drug screening and toxicity testing, which is offering a positive market outlook. Additionally, microfluidics and lab-on-a-chip technologies enable the development of miniaturized and automated cell-based assays that assist in increasing throughput and efficiency in drug discovery. In line with this, the integration of these advanced cell culture technologies into cell-based assays aids in enhancing their relevance and applicability, which makes them suitable tools for understanding disease mechanisms and evaluating drug candidates with greater precision.

Cell-Based Assay Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cell-based assay market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and services, technology, application and end-user.

Breakup by Product and Services:

Consumables

Reagents and Media

Cells and Cell Lines

Probes and Labels

Instruments

Microplates

Microplate Readers

High Throughput Screening

Liquid Handling Systems

Services

Software

Consumables represent the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product and services. This includes consumables (reagents and media, cells and cell lines, and probes and labels), instruments (microplates, microplate readers, high throughput screening, and liquid handling systems), services, and software. According to the report, consumables represented the largest segment. Consumables refer to a wide range of disposable laboratory materials and reagents that are essential for conducting cell-based experiments and assays. They include cell culture media, reagents for cell proliferation and viability assays, cell culture plates, assay kits, antibodies, and other materials used on a one-time or limited-use basis. In addition, consumables ensure the proper growth and maintenance of cells in culture and provide the necessary tools for detecting cellular responses that enable the execution of various assays efficiently. They play a crucial role in ensuring the accuracy, reproducibility, and reliability of results in cell-based experiments.

Breakup by Technology:

Automated Handling

Flow Cytometry

Label-Free Detection

High-Throughput Screening

Others

High-throughput screening accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes automated handling, flow cytometry, label-free detection, high-throughput screening, and others. According to the report, high-throughput screening represented the largest segment. High-throughput screening (HTS) is a technology-driven approach used in drug discovery, which allows researchers to quickly test thousands to millions of compounds for their biological activity. HTS systems are designed to automate the screening process and enable the rapid evaluation of potential drug candidates. It involves the use of robotic systems and specialized equipment to perform assays on a large scale. It typically utilizes microplates with multiple wells, where each well contains cells or biochemical components for testing. The technology allows for the identification of compounds that exhibit desired biological effects, such as binding to a specific target or modulating a cellular response.

Breakup by Application:

Drug Discovery

Basic Research

ADME Studies

Predictive Toxicology

Others

Drug discovery dominates the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes drug discovery, basic research, ADME studies, predictive toxicology, and others. According to the report, drug discovery represented the largest segment. Drug discovery refers to the techniques and technologies used to administer therapeutic substances, such as drugs or biologics, to the targeted cells or tissues within the body. These assays play a critical role in the development and optimization of drug delivery systems by providing valuable insights into their efficacy and safety. In addition, they are used to assess targeted delivery, screen for cellular uptake, evaluate drug release kinetics, and assay drug toxicity. Researchers employ cell-based models to evaluate the ability of drug delivery systems, such as nanoparticles or liposomes, to specifically target and interact with particular cell types or tissues.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies

Academic and Government Institutions

Contract Research Organizations

Others

Pharmaceutical and biotechnology companies hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment. Pharmaceutical and biotechnology employ these assays to identify and validate potential drug candidates, assess their efficacy, and evaluate safety profiles. They enable high-throughput screening of compound libraries that enhance the drug development pipeline. In line with this, these companies utilize these assays to ensure the safety of drug candidates. These assays assist in assessing the cytotoxicity and potential adverse effects of compounds that benefit companies complying with regulatory requirements. Moreover, these assays are employed for quality control purposes to ensure the consistency and reliability of pharmaceutical and biotechnological products.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest cell-based assay market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing demand for advanced assay technologies and consumables. In addition, the rising development of novel cell-based assay techniques is bolstering the growth of the market in the region. Apart from this, the growing focus on drug safety is positively influencing the market. In line with this, stringent regulatory standards are propelling the growth of the market in the North America region.

Competitive Landscape:

Major players are developing innovative assay technologies, such as novel reagents, assay kits, and platforms. This involves creating more physiologically relevant cell models to improve assay sensitivity and enhance automation and data analysis capabilities. In line with this, companies are expanding their product portfolios to cater to a wide range of applications. This includes offering assays tailored for specific targets, pathways, or disease models, and developing specialized kits for toxicity testing and drug screening. Apart from this, key manufacturers are providing customized assay development services and are working closely with clients to tailor assays to their specific research needs, which is offering a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Becton, Dickinson and Company

Global Life Sciences Solutions USA LLC (DBA Cytiva)

Thermo Fisher Scientific Inc.

Merck Group

PerkinElmer Inc.

Charles River Laboratories Inc.

Lonza Group Ltd.

Cell Signaling Technology

Promega Corporation

Cell Biolabs Inc.

Eurofins DiscoverX Corporation

Bio-Rad Laboratories Inc.

Corning Inc.

F. Hoffmann-La Roche AG (Roche Holding AG)

Recent Developments:

In December 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. to provide a complete suite of services across the clinical development spectrum, comprising scientific discovery, safety, efficacy and healthcare outcome assessment, handling trial logistics, and the development and production of the therapeutics.

In March 2022, Promega Corporation and FUJIFILM Cellular Dynamics, Inc. announced a strategic collaboration to advance novel assay development for drug discovery. The collaboration will merge bioluminescent reporter technology used to study cellular signaling and transcriptional activity in iPSCs.

In 2022, BD (Becton, Dickinson and Company) introduced the BD Rhapsody(TM) TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system and provide a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases.

Key Questions Answered in This Report

• 1. What was the size of the global cell-based assay market in 2023?
• 2. What is the expected growth rate of the global cell-based assay market during 2024-2032?
• 3. What are the key factors driving the global cell-based assay market?
• 4. What has been the impact of COVID-19 on the global cell-based assay market?
• 5. What is the breakup of the global cell-based assay market based on the product and services?
• 6. What is the breakup of the global cell-based assay market based on the technology?
• 7. What is the breakup of the global cell-based assay market based on the application?
• 8. What is the breakup of the global cell-based assay market based on the end-user?
• 9. What are the key regions in the global cell-based assay market?
• 10. Who are the key players/companies in the global cell-based assay market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cell-Based Assay Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product and Services
• 5.5 Market Breakup by Technology
• 5.6 Market Breakup by Application
• 5.7 Market Breakup by End-User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast
• 5.10 SWOT Analysis
  • 5.10.1 Overview
  • 5.10.2 Strengths
  • 5.10.3 Weaknesses
  • 5.10.4 Opportunities
  • 5.10.5 Threats
• 5.11 Value Chain Analysis
• 5.12 Porters Five Forces Analysis
  • 5.12.1 Overview
  • 5.12.2 Bargaining Power of Buyers
  • 5.12.3 Bargaining Power of Suppliers
  • 5.12.4 Degree of Competition
  • 5.12.5 Threat of New Entrants
  • 5.12.6 Threat of Substitutes

6 Market Breakup by Product and Services

• 6.1 Consumables
  • 6.1.1 Reagents and Media
    • 6.1.1.1 Market Trends
    • 6.1.1.2 Market Forecast
  • 6.1.2 Cells and Cell Lines
    • 6.1.2.1 Market Trends
    • 6.1.2.2 Market Forecast
  • 6.1.3 Probes and Labels
    • 6.1.3.1 Market Trends
    • 6.1.3.2 Market Forecast
• 6.2 Instruments
  • 6.2.1 Microplates
    • 6.2.1.1 Market Trends
    • 6.2.1.2 Market Forecast
  • 6.2.2 Microplate Readers
    • 6.2.2.1 Market Trends
    • 6.2.2.2 Market Forecast
  • 6.2.3 High Throughput Screening
    • 6.2.3.1 Market Trends
    • 6.2.3.2 Market Forecast
  • 6.2.4 Liquid Handling Systems
    • 6.2.4.1 Market Trends
    • 6.2.4.2 Market Forecast
• 6.3 Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Software
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Automated Handling
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Flow Cytometry
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Label-Free Detection
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 High-Throughput Screening
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Application

• 8.1 Drug Discovery
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Basic Research
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 ADME Studies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Predictive Toxicology
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic and Government Institutions
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Contract Research Organizations
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Europe
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 Competitive Landscape

• 11.1 Market Structure
• 11.2 Key Players
• 11.3 Profiles of Key Players
  • 11.3.1 Becton, Dickinson and Company
  • 11.3.2 Global Life Sciences Solutions USA LLC (DBA Cytiva)
  • 11.3.3 Thermo Fisher Scientific Inc.
  • 11.3.4 Merck Group
  • 11.3.5 PerkinElmer Inc.
  • 11.3.6 Charles River Laboratories Inc.
  • 11.3.7 Lonza Group Ltd.
  • 11.3.8 Cell Signaling Technology
  • 11.3.9 Promega Corporation
  • 11.3.10 Cell Biolabs Inc.
  • 11.3.11 Eurofins DiscoverX Corporation
  • 11.3.12 Bio-Rad Laboratories Inc.
  • 11.3.13 Corning Inc.
  • 11.3.14 F. Hoffmann-La Roche AG (Roche Holding AG)